• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $OTRK

    Ontrak Inc.

    Subscribe to $OTRK
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak, Inc. operates as an artificial intelligence powered, virtualized outpatient healthcare treatment company that provides in-person or telehealth intervention services to health plans and other third-party payors. Its Ontrak PRE (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends care pathways that people are willing to follow, and engages people who aren't getting the care they need. The company's technology-enabled, OnTrak, program is designed to treat health plan members with unaddressed behavioral health conditions that cause or exacerbate chronic medical diseases, such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was founded in 2003 and is headquartered in Santa Monica, California.

    IPO Year:

    Exchange: NASDAQ

    Website: ontrak-inc.com

    Recent Analyst Ratings for Ontrak Inc.

    DatePrice TargetRatingAnalyst
    12/5/2023$4.00Buy
    ROTH MKM
    3/9/2022$13.00 → $2.50Hold
    Canaccord Genuity
    3/9/2022$11.00 → $2.00Sector Perform
    RBC Capital
    8/20/2021$35.00 → $9.00Market Perform → Underperform
    Cowen & Co.
    8/20/2021$15.00Buy → Neutral
    B. Riley Securities
    See more ratings

    Ontrak Inc. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Electronic Data Interchange Market Size to Grow USD 74.36 billion by 2031, Rising Digital Transformation Across Various Industries Propels | The Insight Partners

    NEW YORK, July 21, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the electronic data interchange (EDI) market is observing significant growth owing to the rising digital transformation across various industries and the growing adoption of EDI in small and medium enterprises. The electronic data interchange market was valued at US$34.02 billion in 2024 and is projected to reach US$74.36 billion by 2031; it is expected to register a CAGR of 11.9% during 2025-2031.  The electronic data interchange market comprises an array of components a

    7/21/25 11:30:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health Announces Pricing of $4 Million Public Offering

    Ontrak, Inc. (NASDAQ:OTRK), a leading value-based behavioral healthcare company powered by proprietary AI and engagement technology, today announced the pricing of a public offering of 6,666,667 shares of its common stock (or pre-funded warrants in lieu thereof) and 26,666,668 warrants to purchase up to 26,666,668 shares of its common stock at a combined public offering price of $0.60 per share of common stock and accompanying warrants or at a combined public offering price of $0.5999 per pre-funded warrant and accompanying warrants, which represents the per share public offering price for the common stock and accompanying warrants less the $0.0001 per share exercise price for each pre-fund

    6/27/25 8:30:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health Announces Expansion of Engage Solution for Sentara Health Plans Self-funded Employer Customers

    Ontrak, Inc. (NASDAQ:OTRK), a leading value-based behavioral healthcare company powered by proprietary AI and engagement technology, today announced an expanded partnership with Sentara Health Plans to offer Ontrak's Engage Solution to employer sponsored customers in the Commonwealth of Virginia. Sentara Health Plans is the health plan division of Sentara Health, an integrated, not-for-profit health care delivery system that provides health plan coverage to one million members in Virginia and Florida. Sentara offers programs to support members with chronic illnesses, customized wellness programs, and integrated clinical and behavioral health services—all to help members improve their heal

    6/24/25 8:00:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health Announces 2025 First Quarter Financial Results

    Q1 Revenue of $2.0 million, down 25% year over year Q1 Operating loss of $(5.9) million, a 37% increase year over year Q1 Adjusted EBITDA of $(4.3) million, a 28% decline year over year Company announces securing a $10.0 million financing commitment from Acuitas Capital LLC Company announces recertification by the National Committee for Quality Assurance (NCQA) as a Credentials Verification Organization (CVO) Company to Host Conference Call at 4:30 pm ET Today Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and technology-enabled behavioral healthcare company, today reported its financial results for the first quarter ended March 31, 2025. Manageme

    5/20/25 4:05:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Secures Financing Commitment to Fuel Growth and Innovation

    Ontrak, Inc. (NASDAQ:OTRK), a leading value-based behavioral healthcare company powered by proprietary AI and engagement technology, announced it has secured a $10 million financing commitment from Acuitas Capital, LLC. This financing commitment will support Ontrak's continued growth and innovation in delivering comprehensive behavioral healthcare solutions and is structured to provide Ontrak with the necessary capital to expand its customer base while continuing to drive further advancements in its AI and digital capabilities. The commitment contemplates that Ontrak may raise additional financing from third parties to further support its growth initiatives. Brandon LaVerne, Chief Executiv

    5/20/25 8:00:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health to Report 2025 First Quarter Financial Results on May 20, 2025

    Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the first quarter 2025 on Tuesday, May 20, 2025, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events . Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes before

    5/19/25 4:30:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Achieves NCQA Recertification as a Credentialing Verification Organization

    Ontrak, Inc. (NASDAQ:OTRK), a leading value-based behavioral healthcare company powered by proprietary AI and engagement technology, announced it has been re-certified by the National Committee for Quality Assurance (NCQA) as a Credentials Verification Organization (CVO) for the element of license to practice. This re-certification reaffirms Ontrak's ongoing commitment to maintaining the highest standards of quality and compliance across its suite of healthcare solutions, helping health plan customers effectively meet their accreditation goals. NCQA, a recognized leader in healthcare quality assessment, evaluation, and certification, grants this prestigious re-certification after a volunta

    4/30/25 8:00:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health Announces 2024 Fourth Quarter and Year End Financial Results

    Q4  revenue of $3.1 million, down 11% year over year; and full year revenue of $10.8 million, down 15% year over year Q4 operating loss of $(4.4) million, a 16% decrease year over year; full year operating loss of $(17.8) million, a decrease of 16% year over year Q4 Adjusted EBITDA of $(2.8) million, a 20% improvement year over year; full year Adjusted EBITDA of $(12.8) million, a 13% improvement year over year Company announces new customer partnership with Intermountain Health for Medicare Advantage members Company announces three-year contract extension with Sentara Health Plans following several expansions in 2024 Company to Host Conference Call at 4:30 pm ET Today Ontrak,

    4/14/25 4:05:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health to Report 2024 Fourth Quarter Financial Results on April 14, 2025

    Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the fourth quarter 2024 on Monday, April 14, 2025, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/delivering-a-healthier-future-for-all/presentations-events/. Participants interested in dialing in to the conference call are requested to register a day in advance or

    4/10/25 4:05:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Secures Medicaid Provider Designation in Two New States, Enhancing Direct Service Delivery Capabilities

    Ontrak, Inc (NASDAQ:OTRK), a leading AI-powered and telehealth-enabled behavioral healthcare company today announced that a new affiliated practice association has secured official Medicaid designation in two new states. The first is a midwestern state, as talks continue with a large Midwestern Health Plan regarding the potential implementation of its WholeHealth+ solution in their region. The second is a southeastern state that will enable enhancing its solutions for one of its customers and future prospects. Medicaid affiliation enables Ontrak to operate as a direct value-based provider in addition to its historical operations as a vendor. As a value-based care provider, Ontrak can align

    4/3/25 8:00:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Inc. SEC Filings

    View All

    SEC Form NT 10-Q filed by Ontrak Inc.

    NT 10-Q - Ontrak, Inc. (0001136174) (Filer)

    8/15/25 6:36:38 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Ontrak, Inc. (0001136174) (Filer)

    8/13/25 4:13:55 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Inc. filed SEC Form 8-K: Other Events, Leadership Update

    8-K - Ontrak, Inc. (0001136174) (Filer)

    7/31/25 11:04:55 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Inc. filed SEC Form 8-K: Other Events

    8-K - Ontrak, Inc. (0001136174) (Filer)

    7/7/25 9:00:29 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - Ontrak, Inc. (0001136174) (Filer)

    7/3/25 5:03:48 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - Ontrak, Inc. (0001136174) (Filer)

    6/30/25 5:24:52 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 424B5 filed by Ontrak Inc.

    424B5 - Ontrak, Inc. (0001136174) (Filer)

    6/30/25 10:00:23 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form EFFECT filed by Ontrak Inc.

    EFFECT - Ontrak, Inc. (0001136174) (Filer)

    6/27/25 12:15:18 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form S-1/A filed by Ontrak Inc.

    S-1/A - Ontrak, Inc. (0001136174) (Filer)

    6/20/25 4:52:27 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form S-1 filed by Ontrak Inc.

    S-1 - Ontrak, Inc. (0001136174) (Filer)

    6/16/25 9:36:13 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Peizer Terren S exercised 500,000 in-the-money shares at a strike of $0.00 (SEC Form 4)

    4 - Ontrak, Inc. (0001136174) (Issuer)

    6/24/25 6:32:14 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Large owner Peizer Terren S

    4 - Ontrak, Inc. (0001136174) (Issuer)

    6/23/25 8:06:38 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Chief Financial Officer Park James J converted options into 4 shares and covered exercise/tax liability with 1 shares, increasing direct ownership by 33% to 12 units (SEC Form 4)

    4 - Ontrak, Inc. (0001136174) (Issuer)

    6/17/25 5:33:52 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Large owner Peizer Terren S

    4 - Ontrak, Inc. (0001136174) (Issuer)

    5/29/25 9:30:10 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Large owner Peizer Terren S

    4 - Ontrak, Inc. (0001136174) (Issuer)

    5/20/25 5:31:02 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Large owner Peizer Terren S

    4 - Ontrak, Inc. (0001136174) (Issuer)

    4/1/25 9:24:56 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Director Sherman Michael Edward

    4 - Ontrak, Inc. (0001136174) (Issuer)

    1/6/25 8:08:28 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Director Berman Richard A

    4 - Ontrak, Inc. (0001136174) (Issuer)

    1/6/25 7:30:22 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Director Messina James M.

    4 - Ontrak, Inc. (0001136174) (Issuer)

    1/6/25 7:27:18 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Director Sherman Michael Edward sold $306 worth of shares (173 units at $1.77), closing all direct ownership in the company (SEC Form 4)

    4 - Ontrak, Inc. (0001136174) (Issuer)

    11/22/24 9:00:51 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    ROTH MKM initiated coverage on Ontrak with a new price target

    ROTH MKM initiated coverage of Ontrak with a rating of Buy and set a new price target of $4.00

    12/5/23 8:03:01 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Canaccord Genuity reiterated coverage on Ontrak with a new price target

    Canaccord Genuity reiterated coverage of Ontrak with a rating of Hold and set a new price target of $2.50 from $13.00 previously

    3/9/22 9:09:19 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    RBC Capital reiterated coverage on Ontrak with a new price target

    RBC Capital reiterated coverage of Ontrak with a rating of Sector Perform and set a new price target of $2.00 from $11.00 previously

    3/9/22 7:43:55 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak downgraded by Cowen & Co. with a new price target

    Cowen & Co. downgraded Ontrak from Market Perform to Underperform and set a new price target of $9.00 from $35.00 previously

    8/20/21 5:19:18 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak downgraded by B. Riley Securities with a new price target

    B. Riley Securities downgraded Ontrak from Buy to Neutral and set a new price target of $15.00

    8/20/21 5:16:34 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak upgraded by Canaccord Genuity with a new price target

    Canaccord Genuity upgraded Ontrak from Hold to Buy and set a new price target of $46.00 from $32.00 previously

    3/16/21 12:02:15 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak upgraded by Canaccord Genuity

    Canaccord Genuity upgraded Ontrak from Hold to Buy

    3/16/21 11:40:13 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Canaccord Genuity reiterated coverage on Ontrak with a new price target

    Canaccord Genuity reiterated coverage of Ontrak with a rating of Hold and set a new price target of $32.00 from $30.00 previously

    3/15/21 8:08:37 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Canaccord Genuity reiterated coverage on Ontrak with a new price target

    Canaccord Genuity reiterated coverage of Ontrak with a rating of Hold and set a new price target of $32.00 from $30.00 previously

    3/10/21 10:02:13 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Royal Bank of Canada resumed coverage on Ontrak with a new price target

    Royal Bank of Canada resumed coverage of Ontrak with a rating of Sector Perform and set a new price target of $32.00 from $82.00 previously

    3/8/21 8:23:14 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Inc. Leadership Updates

    Live Leadership Updates

    View All

    Ontrak Names James Messina to its Board of Directors

    Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of James Messina as a non-Executive Director to its board. Mr. Messina is a Co-Founder and General Partner of Seattle Hill Ventures and x4 Capital Partners, which invest in, and support, startup ventures by providing business development, marketing, operating and technology support. Previously, Mr. Messina was the Executive Vice President and Chief Operating Officer for Premera Blue Cross ("Premera"). He was responsible for effectively servicing the needs of Premera's customers with oversight of all operational functions, from customer serv

    8/30/22 8:00:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Names Dr. Robert Accordino Chief Medical Officer

    Mental Healthcare Leader and Harvard Medical School Faculty Member Joins Ontrak Ontrak, Inc (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of Dr. Robert Accordino as Ontrak's Chief Medical Officer, effective September 27, 2021. Dr. Accordino joins Ontrak from Quartet Health where he served as the company's most senior clinician and Chief Mental Health Officer. He practices psychiatry and is on the faculty of Harvard Medical School and Massachusetts General Hospital. Dr. Accordino will report to Jonathan Mayhew, CEO, who joined Ontrak from CVS Health earlier this year. "Dr. Accordino's reputation in

    9/9/21 8:00:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Arik Hill Joins Ontrak as Chief Information Officer

    Former Accenture and KPMG Healthcare Expert Brings Proven Leadership Experience In Behavioral Health Digital Transformation Ontrak, Inc (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of Arik Hill as Ontrak's first Chief Information Officer, effective August 30, 2021. Mr. Hill will report to Jonathan Mayhew, CEO, who joined Ontrak from CVS Health earlier this year. "As Chief Information Officer at The New York Foundling, a fast growing organization that collaborates with over 250,000 behavioral healthcare partners across the country, Arik led the development of digital platforms and applications th

    8/12/21 8:00:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Selects Mary Louise Osborne as Company's First Chief Customer Officer

    Osborne brings proven track record of leadership in growth and expansions of multi-billion dollar government and commercial businesses at CVS Health, Aetna and Coventry Health Care Ontrak, Inc (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of former CVS Health (NYSE:CVS) Regional Vice President and former President of Government business at Coventry Health Care Mary Louise Osborne as Ontrak's first Chief Customer Officer, effective August 30, 2021. Ms. Osborne will report to Jonathan Mayhew, CEO, who joined Ontrak from CVS in April. "Mary Lou brings decades of progressive management experience and

    8/10/21 8:00:00 AM ET
    $CVS
    $OTRK
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Appoints CVS Health’s Chief Transformation Officer, Jonathan Mayhew, as Chief Executive Officer

    SANTA MONICA, Calif.--(BUSINESS WIRE)--Ontrak, Inc (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized healthcare company, today announced the appointment of CVS Health (NYSE: CVS) Executive Vice President and Chief Transformation Officer Jonathan Mayhew as Ontrak Chief Executive Officer effective April 12, 2021. Terren Peizer, who founded the company 17 years ago and served as CEO and Chairman through the company’s launch and expansion of national health plan contracts, was named Executive Chairman. Peizer will continue to serve as Chairman of the Ontrak Board of Directors and remains majority shareholder. “It’s been a tremendous

    3/16/21 8:40:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ontrak Inc.

    SC 13G/A - Ontrak, Inc. (0001136174) (Subject)

    11/14/24 4:24:03 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Ontrak Inc.

    SC 13D/A - Ontrak, Inc. (0001136174) (Subject)

    10/3/24 6:37:08 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Ontrak Inc.

    SC 13D/A - Ontrak, Inc. (0001136174) (Subject)

    8/30/24 5:15:15 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Ontrak Inc.

    SC 13D/A - Ontrak, Inc. (0001136174) (Subject)

    6/25/24 7:45:11 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13D/A filed by Ontrak Inc. (Amendment)

    SC 13D/A - Ontrak, Inc. (0001136174) (Subject)

    6/5/24 5:21:13 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13D/A filed by Ontrak Inc. (Amendment)

    SC 13D/A - Ontrak, Inc. (0001136174) (Subject)

    4/10/24 5:20:55 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13D/A filed by Ontrak Inc. (Amendment)

    SC 13D/A - Ontrak, Inc. (0001136174) (Subject)

    4/1/24 5:20:56 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Ontrak Inc.

    SC 13G - Ontrak, Inc. (0001136174) (Subject)

    2/14/24 3:48:52 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13D/A filed by Ontrak Inc. (Amendment)

    SC 13D/A - Ontrak, Inc. (0001136174) (Subject)

    12/22/23 5:20:12 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13D/A filed by Ontrak Inc. (Amendment)

    SC 13D/A - Ontrak, Inc. (0001136174) (Subject)

    11/15/23 5:24:03 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Inc. Financials

    Live finance-specific insights

    View All

    Ontrak Health Announces 2025 First Quarter Financial Results

    Q1 Revenue of $2.0 million, down 25% year over year Q1 Operating loss of $(5.9) million, a 37% increase year over year Q1 Adjusted EBITDA of $(4.3) million, a 28% decline year over year Company announces securing a $10.0 million financing commitment from Acuitas Capital LLC Company announces recertification by the National Committee for Quality Assurance (NCQA) as a Credentials Verification Organization (CVO) Company to Host Conference Call at 4:30 pm ET Today Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and technology-enabled behavioral healthcare company, today reported its financial results for the first quarter ended March 31, 2025. Manageme

    5/20/25 4:05:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health to Report 2025 First Quarter Financial Results on May 20, 2025

    Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the first quarter 2025 on Tuesday, May 20, 2025, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events . Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes before

    5/19/25 4:30:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health to Report 2024 Fourth Quarter Financial Results on April 14, 2025

    Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the fourth quarter 2024 on Monday, April 14, 2025, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/delivering-a-healthier-future-for-all/presentations-events/. Participants interested in dialing in to the conference call are requested to register a day in advance or

    4/10/25 4:05:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health Announces 2024 Third Quarter Financial Results

    Q3 Revenue of $2.6 million, down 31% year-over-year Q3 Operating loss of $(5.1) million, a 26% increase year-over-year Q3 Adjusted EBITDA of $(3.3) million, a 24% decline year-over-year Company announces expansion of behavioral health solutions with Sentara Health for Commercial and Marketplace members Company begins enrollment of new members into Ontrak's WholeHealth+ solution under a new contract with a large northeast regional health plan and announces expansion of its services with Ontrak Quality solution Company announces a reverse split of its common stock at a ratio of 1-for-15, which was effective at 12:01 a.m. Eastern Time on September 23, 2024 Company to Host Co

    11/13/24 4:05:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health to Report 2024 Third Quarter Financial Results on November 13, 2024

    Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the third quarter 2024 on Wednesday, November 13, 2024, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events/. Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes

    10/31/24 4:30:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health Announces Expected 2024 Second Quarter Financial Results

    Q2 Revenue of $2.5 million, down 17% year over year Q2 Operating loss of $(4.0) million, a 13% improvement year over year Q2 Adjusted EBITDA of $(3.3) million, an 8% decline year over year Company announces new contract with large northeast regional health plan Company announces final results of a formal evaluation showing achievement of $721 per member per month cost savings for a prominent health plan's members Company announced the adoption of the Comprehensive Healthcare Integration (CHI) framework into its care delivery model Company to Host Conference Call at 4:30 pm ET Today Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and technol

    8/8/24 4:05:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health to Report 2024 Second Quarter Financial Results on August 8, 2024

    Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the second quarter 2024 on Thursday, August 8, 2024, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events. Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes b

    7/25/24 4:05:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health to Report 2024 First Quarter Financial Results on May 14, 2024

    Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the first quarter 2024 on Tuesday, May 14, 2024, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events. Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes befor

    5/1/24 4:05:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak to Report 2023 Fourth Quarter Financial Results on April 16, 2024

    Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the fourth quarter 2024 on Tuesday, April 16, 2024, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events. Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes bef

    4/3/24 4:05:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak to Report 2023 Third Quarter Financial Results on November 14, 2023

    Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the third quarter 2023 on Tuesday, November 14, 2023, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events . Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes

    10/31/23 4:05:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care